<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Adverse Events by System Organ Class and Preferred Term — t_ae • osprey</title>


<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js" integrity="sha256-FgpCb/KJQlLNfOu91ta32o/NMZxltwRo8QtmkMRdAu8=" crossorigin="anonymous"></script>
<!-- Bootstrap -->
<link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.3.7/cerulean/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous" />


<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha256-U5ZEeKfGNOja007MMD3YBI0A3OSZOQbeG6z2f2Y0hu8=" crossorigin="anonymous"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.7.1/css/all.min.css" integrity="sha256-nAmazAk6vS34Xqo0BSrTb+abbtFlgsFK7NKSi6o7Y78=" crossorigin="anonymous" />
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.7.1/css/v4-shims.min.css" integrity="sha256-6qHlizsOWFskGlwVOKuns+D1nB6ssZrHQrNj1wGplHc=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.4/clipboard.min.js" integrity="sha256-FiZwavyI2V6+EXO1U+xzLG3IKldpiTFf3153ea9zikQ=" crossorigin="anonymous"></script>

<!-- headroom.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.9.4/headroom.min.js" integrity="sha256-DJFC1kqIhelURkuza0AvYal5RxMtpzLjFhsnVIeuk+U=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.9.4/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>




<meta property="og:title" content="Adverse Events by System Organ Class and Preferred Term — t_ae" />
<meta property="og:description" content="t_ae returns adverse events summary table that corresponds to STREAM template AET02" />
<meta name="twitter:card" content="summary" />


<meta name="robots" content="noindex">

<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->



  </head>

  <body>
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">osprey</a>
        <span class="version label label-danger" data-toggle="tooltip" data-placement="bottom" title="In-development version">0.1.4</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fas fa fas fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
<!-- start_releases -->
<li class="dropdown"><a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
Other releases
<span class="caret"></span></a><ul class="dropdown-menu" role="menu">
   <li><a href="../../index.html">latest</a></li>
   <li><a href="../../v0.1.10/index.html">v0.1.10</a></li>
   <li><a href="../../v0.1.9/index.html">v0.1.9</a></li>
   <li><a href="../../v0.1.8/index.html">v0.1.8</a></li>
   <li><a href="../../v0.1.7/index.html">v0.1.7</a></li>
   <li><a href="../../v0.1.6/index.html">v0.1.6</a></li>
   <li><a href="../../v0.1.5/index.html">v0.1.5</a></li>
   <li><a href="../../v0.1.4/index.html">v0.1.4</a></li>
   <li><a href="../../v0.1.3/index.html">v0.1.3</a></li>
</ul></li>
<!-- end_releases -->
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.roche.com/Rpackages/osprey">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Adverse Events by System Organ Class and Preferred Term</h1>
    
    <div class="hidden name"><code>t_ae.Rd</code></div>
    </div>

    <div class="ref-description">
    <p><code>t_ae</code> returns adverse events summary table that corresponds to STREAM template AET02</p>
    </div>

    <pre class="usage"><span class='fu'>t_ae</span>(<span class='no'>class</span>, <span class='no'>term</span>, <span class='no'>id</span>, <span class='no'>col_by</span>, <span class='kw'>total</span> <span class='kw'>=</span> <span class='st'>"All Patients"</span>)</pre>

    <h2 class="hasAnchor" id="arguments"><a class="anchor" href="#arguments"></a>Arguments</h2>
    <table class="ref-arguments">
    <colgroup><col class="name" /><col class="desc" /></colgroup>
    <tr>
      <th>class</th>
      <td><p>system organ class variable.</p></td>
    </tr>
    <tr>
      <th>term</th>
      <td><p>preferred term variable.</p></td>
    </tr>
    <tr>
      <th>id</th>
      <td><p>unique subject identifier variable. If a particular subject has no
adverse event then the subject <code>id</code> should be listed where
<code>class</code> and <code>term</code> should be set to missing (i.e. <code>NA</code>).</p></td>
    </tr>
    <tr>
      <th>col_by</th>
      <td><p>group variable that will be used for a column header. <code>col_by</code>
has to be a factor and can not be missing.</p></td>
    </tr>
    <tr>
      <th>total</th>
      <td><p>character string that will be used as a label for a column with
pooled total population, default here is "All Patients", if set to <code>NULL</code> then
the "All Patients" column is suppressed.</p></td>
    </tr>
    </table>

    <h2 class="hasAnchor" id="value"><a class="anchor" href="#value"></a>Value</h2>

    <p><code>rtable</code> object</p>
    <h2 class="hasAnchor" id="details"><a class="anchor" href="#details"></a>Details</h2>

    <p>this is an equivalent of the STREAM output <code>%stream_t_summary(templates = aet02)</code>
  (<a href='http://bioportal.roche.com/stream_doc/2_05/um/report_outputs_aet02.html'>http://bioportal.roche.com/stream_doc/2_05/um/report_outputs_aet02.html</a>)</p>

    <h2 class="hasAnchor" id="examples"><a class="anchor" href="#examples"></a>Examples</h2>
    <pre class="examples"><div class='input'><span class='co'># Simple example</span>
<span class='fu'><a href='https://rdrr.io/r/base/library.html'>library</a></span>(<span class='no'>dplyr</span>)

<span class='no'>ASL</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='https://dplyr.tidyverse.org/reference/reexports.html'>tibble</a></span>(
  <span class='kw'>USUBJID</span> <span class='kw'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/paste.html'>paste0</a></span>(<span class='st'>"id-"</span>, <span class='fl'>1</span>:<span class='fl'>10</span>),
  <span class='kw'>ARM</span> <span class='kw'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/paste.html'>paste</a></span>(<span class='st'>"ARM"</span>, <span class='no'>LETTERS</span>[<span class='fu'><a href='https://rdrr.io/r/base/rep.html'>rep</a></span>(<span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span>(<span class='fl'>1</span>, <span class='fl'>2</span>), <span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span>(<span class='fl'>3</span>, <span class='fl'>7</span>))])
)


<span class='no'>ae_lookup</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='https://dplyr.tidyverse.org/reference/reexports.html'>tribble</a></span>(
  ~<span class='no'>CLASS</span>, ~<span class='no'>TERM</span>, ~<span class='no'>GRADE</span>,
  <span class='st'>"cl A"</span>, <span class='st'>"trm A_1/2"</span>, <span class='fl'>1</span>,
  <span class='st'>"cl A"</span>, <span class='st'>"trm A_2/2"</span>, <span class='fl'>2</span>,
  <span class='st'>"cl B"</span>, <span class='st'>"trm B_1/3"</span>, <span class='fl'>2</span>,
  <span class='st'>"cl B"</span>, <span class='st'>"trm B_2/3"</span>, <span class='fl'>3</span>,
  <span class='st'>"cl B"</span>, <span class='st'>"trm B_3/3"</span>, <span class='fl'>1</span>,
  <span class='st'>"cl C"</span>, <span class='st'>"trm C_1/1"</span>, <span class='fl'>1</span>
)

<span class='no'>AAE</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='https://rdrr.io/r/base/cbind.html'>cbind</a></span>(
  <span class='fu'><a href='https://dplyr.tidyverse.org/reference/reexports.html'>tibble</a></span>(
    <span class='kw'>USUBJID</span> <span class='kw'>=</span> <span class='no'>ASL</span>$<span class='no'>USUBJID</span>[<span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span>(<span class='fl'>2</span>, <span class='fl'>2</span>, <span class='fl'>2</span>, <span class='fl'>3</span>, <span class='fl'>3</span>, <span class='fl'>4</span>, <span class='fl'>4</span>, <span class='fl'>4</span>, <span class='fl'>4</span>, <span class='fl'>5</span>, <span class='fl'>6</span>, <span class='fl'>6</span>, <span class='fl'>7</span>, <span class='fl'>7</span>)]
  ),
  <span class='no'>ae_lookup</span>[<span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span>(<span class='fl'>1</span>, <span class='fl'>1</span>, <span class='fl'>2</span>, <span class='fl'>6</span>, <span class='fl'>4</span>, <span class='fl'>2</span>, <span class='fl'>2</span>, <span class='fl'>3</span>, <span class='fl'>4</span>, <span class='fl'>2</span>, <span class='fl'>1</span>, <span class='fl'>5</span>, <span class='fl'>4</span>, <span class='fl'>6</span>), ]
)

<span class='no'>ANL</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='https://dplyr.tidyverse.org/reference/join.html'>left_join</a></span>(<span class='no'>ASL</span>, <span class='no'>AAE</span>, <span class='kw'>by</span> <span class='kw'>=</span> <span class='st'>"USUBJID"</span>)



<span class='no'>tbl</span> <span class='kw'>&lt;-</span> <span class='fu'>t_ae</span>(
  <span class='kw'>class</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>CLASS</span>,
  <span class='kw'>term</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>TERM</span>,
  <span class='kw'>id</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>USUBJID</span>,
  <span class='kw'>col_by</span> <span class='kw'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/factor.html'>factor</a></span>(<span class='no'>ANL</span>$<span class='no'>ARM</span>),
  <span class='kw'>total</span> <span class='kw'>=</span> <span class='st'>"All Patients"</span>
)
<span class='no'>tbl</span></div><div class='output co'>#&gt; ANL$CLASS                                                            ARM A               ARM B            All Patients
#&gt;   ANL$TERM                                                           (N=3)               (N=7)               (N=10)   
#&gt; ----------------------------------------------------------------------------------------------------------------------
#&gt; Total number of patients with at least one adverse event           2 (66.7%)           4 (57.1%)            6 (60%)   
#&gt; 
#&gt; Overall total number of events                                         5                   9                   14     
#&gt; 
#&gt; cl A
#&gt;   Total number of patients with at least one adverse event         1 (33.3%)           3 (42.9%)            4 (40%)   
#&gt;   Total number of events                                               3                   4                   7      
#&gt;   trm A_2/2                                                        1 (33.3%)           2 (28.6%)            3 (30%)   
#&gt;   trm A_1/2                                                        1 (33.3%)           1 (14.3%)            2 (20%)   
#&gt; 
#&gt; cl B
#&gt;   Total number of patients with at least one adverse event         1 (33.3%)           3 (42.9%)            4 (40%)   
#&gt;   Total number of events                                               1                   4                   5      
#&gt;   trm B_2/3                                                        1 (33.3%)           2 (28.6%)            3 (30%)   
#&gt;   trm B_1/3                                                            0               1 (14.3%)            1 (10%)   
#&gt;   trm B_3/3                                                            0               1 (14.3%)            1 (10%)   
#&gt; 
#&gt; cl C
#&gt;   Total number of patients with at least one adverse event         1 (33.3%)           1 (14.3%)            2 (20%)   
#&gt;   Total number of events                                               1                   1                   2      
#&gt;   trm C_1/1                                                        1 (33.3%)           1 (14.3%)            2 (20%)   </div><div class='input'>
<span class='co'># Simple example 2</span>

<span class='no'>ADSL</span> <span class='kw'>&lt;-</span> <span class='no'>rADSL</span> <span class='kw'>%&gt;%</span> <span class='fu'><a href='https://dplyr.tidyverse.org/reference/select.html'>select</a></span>(<span class='no'>USUBJID</span>, <span class='no'>STUDYID</span>, <span class='no'>ARM</span>)
<span class='no'>AAE</span> <span class='kw'>&lt;-</span> <span class='no'>rADAE</span> <span class='kw'>%&gt;%</span> <span class='fu'><a href='https://dplyr.tidyverse.org/reference/select.html'>select</a></span>(<span class='no'>USUBJID</span>, <span class='no'>STUDYID</span>, <span class='no'>ARM</span>, <span class='no'>AEBODSYS</span>, <span class='no'>AEDECOD</span>)
<span class='no'>ANL</span> <span class='kw'>&lt;-</span> <span class='fu'><a href='https://dplyr.tidyverse.org/reference/join.html'>left_join</a></span>(<span class='no'>AAE</span>, <span class='no'>ADSL</span>, <span class='kw'>by</span> <span class='kw'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span>(<span class='st'>"USUBJID"</span>, <span class='st'>"STUDYID"</span>, <span class='st'>"ARM"</span>))


<span class='no'>tbl2</span> <span class='kw'>&lt;-</span> <span class='fu'>t_ae</span>(
  <span class='kw'>class</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>AEBODSYS</span>,
  <span class='kw'>term</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>AEDECOD</span>,
  <span class='kw'>id</span> <span class='kw'>=</span> <span class='no'>ANL</span>$<span class='no'>USUBJID</span>,
  <span class='kw'>col_by</span> <span class='kw'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/factor.html'>factor</a></span>(<span class='no'>ANL</span>$<span class='no'>ARM</span>),
  <span class='kw'>total</span> <span class='kw'>=</span> <span class='kw'>NULL</span>
)
<span class='no'>tbl2</span></div><div class='output co'>#&gt; Body System or Organ Class                                                   A: Placebo            B: Drug X           C: Combination
#&gt;   Dictionary Derived Term                                                      (N=11)                (N=21)                (N=18)    
#&gt; -------------------------------------------------------------------------------------------------------------------------------------
#&gt; Total number of patients with at least one adverse event                     11 (100%)             21 (100%)             18 (100%)   
#&gt; 
#&gt; Overall total number of events                                                   65                   133                    99      
#&gt; 
#&gt; Investigations
#&gt;   Total number of patients with at least one adverse event                   6 (54.5%)             12 (57.1%)            10 (55.6%)  
#&gt;   Total number of events                                                         8                     16                    20      
#&gt;   Amniocentesis normal                                                           0                     0                  1 (5.6%)   
#&gt;   Anti factor VIII antibody test                                                 0                     0                  1 (5.6%)   
#&gt;   Anti-aquaporin-4 antibody                                                      0                     0                  1 (5.6%)   
#&gt;   Antibody test negative                                                         0                  1 (4.8%)                 0       
#&gt;   Antidepressant drug clearance increased                                        0                     0                  1 (5.6%)   
#&gt;   Aspergillus test negative                                                   1 (9.1%)                 0                     0       
#&gt;   Beta 2 microglobulin decreased                                                 0                     0                  1 (5.6%)   
#&gt;   Biopsy soft tissue                                                          1 (9.1%)                 0                     0       
#&gt;   Blood beta-D-glucan normal                                                     0                     0                  1 (5.6%)   
#&gt;   Blood bicarbonate                                                              0                     0                  1 (5.6%)   
#&gt;   Blood glucagon normal                                                          0                     0                  1 (5.6%)   
#&gt;   Blood oestrogen abnormal                                                       0                     0                  1 (5.6%)   
#&gt;   Blood pressure normal                                                          0                     0                  1 (5.6%)   
#&gt;   Blood selenium                                                                 0                  1 (4.8%)                 0       
#&gt;   Carnitine abnormal                                                             0                  1 (4.8%)                 0       
#&gt;   Cholecystogram intravenous abnormal                                         1 (9.1%)                 0                     0       
#&gt;   Citric acid urine decreased                                                    0                     0                  1 (5.6%)   
#&gt;   Cytokeratin 18                                                                 0                     0                  1 (5.6%)   
#&gt;   Cytokeratin 18 increased                                                       0                     0                  1 (5.6%)   
#&gt;   Dialysis efficacy test                                                         0                  1 (4.8%)                 0       
#&gt;   Drug level                                                                     0                  1 (4.8%)                 0       
#&gt;   Electrocardiogram PQ interval prolonged                                        0                  1 (4.8%)                 0       
#&gt;   Emergency care examination                                                     0                  1 (4.8%)                 0       
#&gt;   Erythroblast count normal                                                      0                     0                  1 (5.6%)   
#&gt;   Flavivirus test negative                                                    1 (9.1%)                 0                     0       
#&gt;   Hepatitis B DNA assay negative                                              1 (9.1%)                 0                     0       
#&gt;   Hepatitis B e antigen negative                                                 0                  1 (4.8%)                 0       
#&gt;   JC polyomavirus test positive                                                  0                  1 (4.8%)                 0       
#&gt;   Karyotype analysis abnormal                                                 1 (9.1%)                 0                     0       
#&gt;   Metamyelocyte percentage increased                                             0                  1 (4.8%)                 0       
#&gt;   Methaemoglobin urine                                                           0                     0                  1 (5.6%)   
#&gt;   Microbiology test abnormal                                                     0                     0                  1 (5.6%)   
#&gt;   Pancreatic polypeptide level increased                                         0                  1 (4.8%)                 0       
#&gt;   Platelet factor 4                                                              0                     0                  1 (5.6%)   
#&gt;   Pregnancy test false positive                                               1 (9.1%)                 0                     0       
#&gt;   Streptococcus test                                                             0                     0                  1 (5.6%)   
#&gt;   Stroke volume                                                                  0                  1 (4.8%)                 0       
#&gt;   Sweat test                                                                  1 (9.1%)                 0                     0       
#&gt;   T-lymphocyte count abnormal                                                    0                  1 (4.8%)                 0       
#&gt;   Urine homocystine present                                                      0                  1 (4.8%)                 0       
#&gt;   Vitamin B12 increased                                                          0                  1 (4.8%)                 0       
#&gt;   Vitamin K increased                                                            0                     0                  1 (5.6%)   
#&gt;   Wedged hepatic venous pressure                                                 0                  1 (4.8%)                 0       
#&gt;   White blood cell count abnormal                                                0                     0                  1 (5.6%)   
#&gt; 
#&gt; Injury, poisoning and procedural complications
#&gt;   Total number of patients with at least one adverse event                   6 (54.5%)             8 (38.1%)             7 (38.9%)   
#&gt;   Total number of events                                                         10                    12                    7       
#&gt;   Acute graft versus host disease in intestine                                   0                  1 (4.8%)                 0       
#&gt;   Administration site macule                                                  1 (9.1%)                 0                     0       
#&gt;   Application site cyst                                                          0                     0                  1 (5.6%)   
#&gt;   Application site plaque                                                     1 (9.1%)                 0                     0       
#&gt;   Carotid artery perforation                                                  1 (9.1%)                 0                     0       
#&gt;   Drug dose omission by device                                                   0                     0                  1 (5.6%)   
#&gt;   Exposure to noise                                                              0                  1 (4.8%)                 0       
#&gt;   Eye muscle entrapment                                                       1 (9.1%)                 0                     0       
#&gt;   Fluorosis dental                                                            1 (9.1%)                 0                     0       
#&gt;   Infusion site joint infection                                               1 (9.1%)                 0                     0       
#&gt;   Infusion site ulcer                                                            0                  1 (4.8%)                 0       
#&gt;   Injection site laceration                                                      0                  1 (4.8%)                 0       
#&gt;   Medical device site phlebitis                                                  0                  1 (4.8%)                 0       
#&gt;   Mitral perforation                                                             0                     0                  1 (5.6%)   
#&gt;   Ocular toxicity                                                                0                  1 (4.8%)                 0       
#&gt;   Off label use                                                                  0                  1 (4.8%)                 0       
#&gt;   Overdose                                                                       0                     0                  1 (5.6%)   
#&gt;   Postmastectomy lymphoedema syndrome                                         1 (9.1%)                 0                     0       
#&gt;   Product communication issue                                                    0                  1 (4.8%)                 0       
#&gt;   Product label confusion                                                        0                  1 (4.8%)                 0       
#&gt;   Prompt effects of radiation                                                    0                  1 (4.8%)                 0       
#&gt;   Refractoriness to platelet transfusion                                         0                  1 (4.8%)                 0       
#&gt;   Shrapnel wound                                                                 0                     0                  1 (5.6%)   
#&gt;   Tongue injury                                                                  0                  1 (4.8%)                 0       
#&gt;   Transfusion microchimerism                                                  1 (9.1%)                 0                     0       
#&gt;   Vaccination site cyst                                                          0                     0                  1 (5.6%)   
#&gt;   Vessel puncture site occlusion                                                 0                     0                  1 (5.6%)   
#&gt;   Wound dehiscence                                                            1 (9.1%)                 0                     0       
#&gt;   Wrong drug administered                                                     1 (9.1%)                 0                     0       
#&gt; 
#&gt; Infections and infestations
#&gt;   Total number of patients with at least one adverse event                   3 (27.3%)             10 (47.6%)            4 (22.2%)   
#&gt;   Total number of events                                                         4                     17                    6       
#&gt;   Anthrax sepsis                                                                 0                  1 (4.8%)              1 (5.6%)   
#&gt;   Abdominal wall abscess                                                         0                  1 (4.8%)                 0       
#&gt;   AIDS retinopathy                                                               0                  1 (4.8%)                 0       
#&gt;   Burkholderia infection                                                         0                  1 (4.8%)                 0       
#&gt;   Carbuncle                                                                      0                  1 (4.8%)                 0       
#&gt;   Chagas' cardiomyopathy                                                         0                  1 (4.8%)                 0       
#&gt;   Cholera                                                                        0                  1 (4.8%)                 0       
#&gt;   Denture stomatitis                                                             0                  1 (4.8%)                 0       
#&gt;   Ear infection fungal                                                           0                     0                  1 (5.6%)   
#&gt;   Epidermodysplasia verruciformis                                                0                     0                  1 (5.6%)   
#&gt;   Gastroenteritis viral                                                       1 (9.1%)                 0                     0       
#&gt;   Hepatitis infectious mononucleosis                                             0                  1 (4.8%)                 0       
#&gt;   Hepatobiliary infection                                                        0                     0                  1 (5.6%)   
#&gt;   Human anaplasmosis                                                          1 (9.1%)                 0                     0       
#&gt;   Infestation                                                                    0                  1 (4.8%)                 0       
#&gt;   JC virus infection                                                             0                  1 (4.8%)                 0       
#&gt;   Lineal gingival erythema                                                       0                  1 (4.8%)                 0       
#&gt;   Miliary pneumonia                                                           1 (9.1%)                 0                     0       
#&gt;   Reoviral infection                                                             0                     0                  1 (5.6%)   
#&gt;   Schistosomiasis bladder                                                     1 (9.1%)                 0                     0       
#&gt;   Splenic infection helminthic                                                   0                  1 (4.8%)                 0       
#&gt;   Systemic mycosis                                                               0                     0                  1 (5.6%)   
#&gt;   Thyroid echinococciasis                                                        0                  1 (4.8%)                 0       
#&gt;   Ureaplasma infection                                                           0                  1 (4.8%)                 0       
#&gt;   Urinary tract infection bacterial                                              0                  1 (4.8%)                 0       
#&gt;   Vulvovaginitis helminthic                                                      0                  1 (4.8%)                 0       
#&gt; 
#&gt; Skin and subcutaneous tissue disorders
#&gt;   Total number of patients with at least one adverse event                   3 (27.3%)             8 (38.1%)             6 (33.3%)   
#&gt;   Total number of events                                                         4                     8                     7       
#&gt;   Acne occupational                                                           1 (9.1%)                 0                     0       
#&gt;   Acral peeling skin syndrome                                                 1 (9.1%)                 0                     0       
#&gt;   Eczema asteatotic                                                              0                  1 (4.8%)                 0       
#&gt;   Erythema ab igne                                                               0                     0                  1 (5.6%)   
#&gt;   Hair growth rate abnormal                                                   1 (9.1%)                 0                     0       
#&gt;   Hyper IgD syndrome                                                             0                     0                  1 (5.6%)   
#&gt;   Hypokeratosis                                                                  0                  1 (4.8%)                 0       
#&gt;   Injection site telangiectasia                                                  0                     0                  1 (5.6%)   
#&gt;   Lip oedema                                                                     0                     0                  1 (5.6%)   
#&gt;   Measles                                                                     1 (9.1%)                 0                     0       
#&gt;   Nail pterygium                                                                 0                     0                  1 (5.6%)   
#&gt;   Netherton's syndrome                                                           0                  1 (4.8%)                 0       
#&gt;   Palpable purpura                                                               0                  1 (4.8%)                 0       
#&gt;   Pruritus                                                                       0                  1 (4.8%)                 0       
#&gt;   Rash rubelliform                                                               0                  1 (4.8%)                 0       
#&gt;   Sea bather's eruption                                                          0                  1 (4.8%)                 0       
#&gt;   Solar lentigo                                                                  0                     0                  1 (5.6%)   
#&gt;   Vulvovaginal pruritus                                                          0                     0                  1 (5.6%)   
#&gt;   Waardenburg syndrome                                                           0                  1 (4.8%)                 0       
#&gt; 
#&gt; Neoplasms benign, malignant and unspecified (incl cysts and polyps)
#&gt;   Total number of patients with at least one adverse event                   2 (18.2%)             8 (38.1%)             6 (33.3%)   
#&gt;   Total number of events                                                         3                     10                    8       
#&gt;   Cardiac lymphangioma                                                           0                     0                  1 (5.6%)   
#&gt;   Cervix adenomatous polyp                                                       0                     0                  1 (5.6%)   
#&gt;   Colorectal cancer stage IV                                                     0                  1 (4.8%)                 0       
#&gt;   Endocrine neoplasm malignant                                                   0                     0                  1 (5.6%)   
#&gt;   Fibrosarcoma metastatic                                                        0                  1 (4.8%)                 0       
#&gt;   Gallbladder adenoma                                                            0                  1 (4.8%)                 0       
#&gt;   Gallbladder papilloma                                                          0                  1 (4.8%)                 0       
#&gt;   Glomus jugulare tumour                                                         0                     0                  1 (5.6%)   
#&gt;   Hereditary non-polyposis colorectal cancer syndrome                            0                  1 (4.8%)                 0       
#&gt;   Hodgkin's disease mixed cellularity refractory                              1 (9.1%)                 0                     0       
#&gt;   Lung carcinoma cell type unspecified stage 0                                   0                  1 (4.8%)                 0       
#&gt;   Malignant bowel obstruction                                                 1 (9.1%)                 0                     0       
#&gt;   Malignant melanoma                                                          1 (9.1%)                 0                     0       
#&gt;   Metastases to uterus                                                           0                  1 (4.8%)                 0       
#&gt;   Mismatch repair cancer syndrome                                                0                     0                  1 (5.6%)   
#&gt;   Ovarian germ cell polyembryoma stage II                                        0                  1 (4.8%)                 0       
#&gt;   Serous cystadenocarcinoma ovary                                                0                     0                  1 (5.6%)   
#&gt;   Small intestine carcinoma stage II                                             0                  1 (4.8%)                 0       
#&gt;   T-cell lymphoma recurrent                                                      0                     0                  1 (5.6%)   
#&gt;   Thyroid neoplasm                                                               0                     0                  1 (5.6%)   
#&gt;   Tumour pain                                                                    0                  1 (4.8%)                 0       
#&gt; 
#&gt; Surgical and medical procedures
#&gt;   Total number of patients with at least one adverse event                   4 (36.4%)             8 (38.1%)             4 (22.2%)   
#&gt;   Total number of events                                                         4                     10                    4       
#&gt;   Salpingo-oophorectomy bilateral                                                0                     0                 2 (11.1%)   
#&gt;   Arterial catheterisation                                                       0                  1 (4.8%)                 0       
#&gt;   Breast reconstruction                                                          0                  1 (4.8%)                 0       
#&gt;   Duodeno-jejunal bypass sleeve therapy                                          0                  1 (4.8%)                 0       
#&gt;   External ear lesion excision                                                   0                  1 (4.8%)                 0       
#&gt;   Local anaesthesia                                                              0                  1 (4.8%)                 0       
#&gt;   Meningeal repair                                                               0                  1 (4.8%)                 0       
#&gt;   Muscle relaxant therapy                                                        0                  1 (4.8%)                 0       
#&gt;   Oesophageal lesion excision                                                 1 (9.1%)                 0                     0       
#&gt;   Percutaneous ethanol injection therapy                                         0                  1 (4.8%)                 0       
#&gt;   Pericardiotomy                                                              1 (9.1%)                 0                     0       
#&gt;   Phlebotomy                                                                     0                  1 (4.8%)                 0       
#&gt;   Premedication                                                               1 (9.1%)                 0                     0       
#&gt;   Resuscitation                                                                  0                     0                  1 (5.6%)   
#&gt;   Transgender operation                                                       1 (9.1%)                 0                     0       
#&gt;   Tubal insufflation                                                             0                     0                  1 (5.6%)   
#&gt;   Wound drainage                                                                 0                  1 (4.8%)                 0       
#&gt; 
#&gt; Gastrointestinal disorders
#&gt;   Total number of patients with at least one adverse event                   3 (27.3%)             7 (33.3%)             3 (16.7%)   
#&gt;   Total number of events                                                         4                     7                     3       
#&gt;   Amoebic colitis                                                             1 (9.1%)                 0                     0       
#&gt;   Anal neoplasm                                                               1 (9.1%)                 0                     0       
#&gt;   Campylobacter colitis                                                          0                  1 (4.8%)                 0       
#&gt;   Currarino syndrome                                                             0                  1 (4.8%)                 0       
#&gt;   Cytomegalovirus enteritis                                                      0                  1 (4.8%)                 0       
#&gt;   Gastric cancer stage 0                                                         0                  1 (4.8%)                 0       
#&gt;   Hypercementosis                                                                0                  1 (4.8%)                 0       
#&gt;   Hypogeusia                                                                     0                  1 (4.8%)                 0       
#&gt;   Oesophageal carcinoma stage 0                                                  0                  1 (4.8%)                 0       
#&gt;   Premenstrual cramps                                                            0                     0                  1 (5.6%)   
#&gt;   Pyogenic granuloma                                                          1 (9.1%)                 0                     0       
#&gt;   Spigelian hernia                                                               0                     0                  1 (5.6%)   
#&gt;   Syphilis anal                                                                  0                     0                  1 (5.6%)   
#&gt;   Vitello-intestinal duct remnant                                             1 (9.1%)                 0                     0       
#&gt; 
#&gt; Blood and lymphatic system disorders
#&gt;   Total number of patients with at least one adverse event                   4 (36.4%)              4 (19%)              4 (22.2%)   
#&gt;   Total number of events                                                         7                     4                     4       
#&gt;   Anaemic hypoxia                                                             1 (9.1%)                 0                     0       
#&gt;   Cold type haemolytic anaemia                                                   0                     0                  1 (5.6%)   
#&gt;   Congenital dysfibrinogenaemia                                                  0                     0                  1 (5.6%)   
#&gt;   Erythrosis                                                                     0                  1 (4.8%)                 0       
#&gt;   Factor IX inhibition                                                        1 (9.1%)                 0                     0       
#&gt;   Follicular dendritic cell sarcoma                                           1 (9.1%)                 0                     0       
#&gt;   High grade B-cell lymphoma Burkitt-like lymphoma recurrent                     0                  1 (4.8%)                 0       
#&gt;   Lymphadenitis viral                                                            0                  1 (4.8%)                 0       
#&gt;   Lymphoid tissue hypoplasia                                                     0                     0                  1 (5.6%)   
#&gt;   Non-Hodgkin's lymphoma stage III                                               0                  1 (4.8%)                 0       
#&gt;   Non-immune heparin associated thrombocytopenia                              1 (9.1%)                 0                     0       
#&gt;   Post transfusion purpura                                                    1 (9.1%)                 0                     0       
#&gt;   Precursor B-lymphoblastic lymphoma                                          1 (9.1%)                 0                     0       
#&gt;   Splenic infarction                                                             0                     0                  1 (5.6%)   
#&gt;   Splenic marginal zone lymphoma                                              1 (9.1%)                 0                     0       
#&gt; 
#&gt; Musculoskeletal and connective tissue disorders
#&gt;   Total number of patients with at least one adverse event                    1 (9.1%)             3 (14.3%)             6 (33.3%)   
#&gt;   Total number of events                                                         1                     3                     6       
#&gt;   Camptodactyly congenital                                                       0                     0                  1 (5.6%)   
#&gt;   Compression fracture                                                           0                     0                  1 (5.6%)   
#&gt;   Congenital kyphoscoliosis                                                   1 (9.1%)                 0                     0       
#&gt;   Infrapatellar fat pad inflammation                                             0                     0                  1 (5.6%)   
#&gt;   Kyphoscoliosis                                                                 0                     0                  1 (5.6%)   
#&gt;   Kyphosis radiation                                                             0                  1 (4.8%)                 0       
#&gt;   Lordosis                                                                       0                  1 (4.8%)                 0       
#&gt;   Musculoskeletal chest pain                                                     0                     0                  1 (5.6%)   
#&gt;   Staphylococcal osteomyelitis                                                   0                  1 (4.8%)                 0       
#&gt;   Temporomandibular joint syndrome                                               0                     0                  1 (5.6%)   
#&gt; 
#&gt; Vascular disorders
#&gt;   Total number of patients with at least one adverse event                   2 (18.2%)              4 (19%)              4 (22.2%)   
#&gt;   Total number of events                                                         2                     4                     6       
#&gt;   Adrenal thrombosis                                                             0                     0                  1 (5.6%)   
#&gt;   Femoral vein perforation                                                       0                     0                  1 (5.6%)   
#&gt;   Hepatic vein embolism                                                          0                  1 (4.8%)                 0       
#&gt;   Hoigne's syndrome                                                              0                  1 (4.8%)                 0       
#&gt;   Iliac artery embolism                                                          0                     0                  1 (5.6%)   
#&gt;   Intracranial arterial fenestration                                          1 (9.1%)                 0                     0       
#&gt;   Parkes-Weber syndrome                                                          0                     0                  1 (5.6%)   
#&gt;   Pharyngeal haematoma                                                           0                  1 (4.8%)                 0       
#&gt;   Portal vein thrombosis                                                         0                     0                  1 (5.6%)   
#&gt;   Post cardiac arrest syndrome                                                1 (9.1%)                 0                     0       
#&gt;   Stroke in evolution                                                            0                  1 (4.8%)                 0       
#&gt;   Superior vena cava syndrome                                                    0                     0                  1 (5.6%)   
#&gt; 
#&gt; Nervous system disorders
#&gt;   Total number of patients with at least one adverse event                   4 (36.4%)             3 (14.3%)             2 (11.1%)   
#&gt;   Total number of events                                                         5                     3                     3       
#&gt;   Baltic myoclonic epilepsy                                                      0                  1 (4.8%)                 0       
#&gt;   Brow ptosis                                                                    0                  1 (4.8%)                 0       
#&gt;   Bulbar poliomyelitis                                                        1 (9.1%)                 0                     0       
#&gt;   Cerebrospinal fistula                                                       1 (9.1%)                 0                     0       
#&gt;   Congenital hemiparesis                                                      1 (9.1%)                 0                     0       
#&gt;   Cornelia de Lange syndrome                                                     0                     0                  1 (5.6%)   
#&gt;   Creutzfeldt-Jakob disease                                                      0                     0                  1 (5.6%)   
#&gt;   Moebius II syndrome                                                            0                  1 (4.8%)                 0       
#&gt;   Postictal state                                                             1 (9.1%)                 0                     0       
#&gt;   Psychomotor hyperactivity                                                      0                     0                  1 (5.6%)   
#&gt;   West Nile viral infection                                                   1 (9.1%)                 0                     0       
#&gt; 
#&gt; Reproductive system and breast disorders
#&gt;   Total number of patients with at least one adverse event                   4 (36.4%)             3 (14.3%)             2 (11.1%)   
#&gt;   Total number of events                                                         4                     3                     2       
#&gt;   Genital injury                                                              1 (9.1%)                 0                     0       
#&gt;   Haemangioma of breast                                                       1 (9.1%)                 0                     0       
#&gt;   Mammary fistula                                                                0                     0                  1 (5.6%)   
#&gt;   Neuroendocrine breast tumour                                                1 (9.1%)                 0                     0       
#&gt;   Organic erectile dysfunction                                                   0                  1 (4.8%)                 0       
#&gt;   Ovarian germ cell teratoma stage I                                             0                  1 (4.8%)                 0       
#&gt;   Phyllodes tumour                                                               0                  1 (4.8%)                 0       
#&gt;   Uterine cervical pain                                                       1 (9.1%)                 0                     0       
#&gt;   Uterine pain                                                                   0                     0                  1 (5.6%)   
#&gt; 
#&gt; Respiratory, thoracic and mediastinal disorders
#&gt;   Total number of patients with at least one adverse event                   2 (18.2%)             5 (23.8%)             2 (11.1%)   
#&gt;   Total number of events                                                         3                     5                     3       
#&gt;   Atelectasis                                                                    0                     0                  1 (5.6%)   
#&gt;   Dyspnoea exertional                                                            0                     0                  1 (5.6%)   
#&gt;   Loeffler's syndrome                                                            0                  1 (4.8%)                 0       
#&gt;   Nasal mucosal ulcer                                                            0                  1 (4.8%)                 0       
#&gt;   Oesophagobronchial fistula                                                  1 (9.1%)                 0                     0       
#&gt;   PFAPA syndrome                                                                 0                  1 (4.8%)                 0       
#&gt;   Pulmonary contusion                                                            0                     0                  1 (5.6%)   
#&gt;   Pulmonary sequestration                                                     1 (9.1%)                 0                     0       
#&gt;   Sinus polyp                                                                    0                  1 (4.8%)                 0       
#&gt;   Squamous cell carcinoma of the hypopharynx                                     0                  1 (4.8%)                 0       
#&gt;   Tracheal stenosis                                                           1 (9.1%)                 0                     0       
#&gt; 
#&gt; Congenital, familial and genetic disorders
#&gt;   Total number of patients with at least one adverse event                   2 (18.2%)              4 (19%)              2 (11.1%)   
#&gt;   Total number of events                                                         2                     6                     2       
#&gt;   Ataxia telangiectasia                                                       1 (9.1%)                 0                     0       
#&gt;   Bladder agenesis                                                            1 (9.1%)                 0                     0       
#&gt;   Cerebral atrophy congenital                                                    0                     0                  1 (5.6%)   
#&gt;   Cobb syndrome                                                                  0                     0                  1 (5.6%)   
#&gt;   Congenital cutis laxa                                                          0                  1 (4.8%)                 0       
#&gt;   Familial amyloidosis                                                           0                  1 (4.8%)                 0       
#&gt;   Gaucher's disease type II                                                      0                  1 (4.8%)                 0       
#&gt;   Haemoglobin E disease                                                          0                  1 (4.8%)                 0       
#&gt;   Mitochondrial hepatopathy                                                      0                  1 (4.8%)                 0       
#&gt;   Wolfram syndrome                                                               0                  1 (4.8%)                 0       
#&gt; 
#&gt; Eye disorders
#&gt;   Total number of patients with at least one adverse event                       0                  4 (19%)              4 (22.2%)   
#&gt;   Total number of events                                                         0                     4                     4       
#&gt;   Chromatopsia                                                                   0                     0                  1 (5.6%)   
#&gt;   Eversion of lacrimal punctum                                                   0                     0                  1 (5.6%)   
#&gt;   Haemangioma of retina                                                          0                  1 (4.8%)                 0       
#&gt;   Macular rupture                                                                0                     0                  1 (5.6%)   
#&gt;   Marfan's syndrome                                                              0                  1 (4.8%)                 0       
#&gt;   Neurologic neglect syndrome                                                    0                     0                  1 (5.6%)   
#&gt;   Pupillary deformity                                                            0                  1 (4.8%)                 0       
#&gt;   Retinal melanoma                                                               0                  1 (4.8%)                 0       
#&gt; 
#&gt; General disorders and administration site conditions
#&gt;   Total number of patients with at least one adverse event                       0                  4 (19%)              3 (16.7%)   
#&gt;   Total number of events                                                         0                     5                     4       
#&gt;   Delirium febrile                                                               0                  1 (4.8%)                 0       
#&gt;   Enzyme inhibition                                                              0                  1 (4.8%)                 0       
#&gt;   General physical health deterioration                                          0                  1 (4.8%)                 0       
#&gt;   Ill-defined disorder                                                           0                     0                  1 (5.6%)   
#&gt;   Multiple organ dysfunction syndrome                                            0                  1 (4.8%)                 0       
#&gt;   Puncture site induration                                                       0                     0                  1 (5.6%)   
#&gt;   Soft tissue inflammation                                                       0                  1 (4.8%)                 0       
#&gt;   Temperature regulation disorder                                                0                     0                  1 (5.6%)   
#&gt;   Vaccination site reaction                                                      0                     0                  1 (5.6%)   
#&gt; 
#&gt; Renal and urinary disorders
#&gt;   Total number of patients with at least one adverse event                       0                  4 (19%)              2 (11.1%)   
#&gt;   Total number of events                                                         0                     4                     2       
#&gt;   Bladder diverticulum                                                           0                  1 (4.8%)                 0       
#&gt;   Cystitis-like symptom                                                          0                  1 (4.8%)                 0       
#&gt;   Persistent urogenital sinus                                                    0                     0                  1 (5.6%)   
#&gt;   Transitional cell cancer of the renal pelvis and ureter regional               0                  1 (4.8%)                 0       
#&gt;   Tubulointerstitial nephritis and uveitis syndrome                              0                     0                  1 (5.6%)   
#&gt;   Urogenital prolapse                                                            0                  1 (4.8%)                 0       
#&gt; 
#&gt; Pregnancy, puerperium and perinatal conditions
#&gt;   Total number of patients with at least one adverse event                    1 (9.1%)             3 (14.3%)              1 (5.6%)   
#&gt;   Total number of events                                                         1                     3                     2       
#&gt;   Congenital hepatitis B infection                                               0                  1 (4.8%)                 0       
#&gt;   Cranial sutures widening                                                    1 (9.1%)                 0                     0       
#&gt;   Foetal malformation                                                            0                  1 (4.8%)                 0       
#&gt;   Oligohydramnios                                                                0                     0                  1 (5.6%)   
#&gt;   Placenta accreta                                                               0                  1 (4.8%)                 0       
#&gt;   Risk of future pregnancy miscarriage                                           0                     0                  1 (5.6%)   
#&gt; 
#&gt; Cardiac disorders
#&gt;   Total number of patients with at least one adverse event                    1 (9.1%)             3 (14.3%)                 0       
#&gt;   Total number of events                                                         1                     3                     0       
#&gt;   Foetal arrhythmia                                                           1 (9.1%)                 0                     0       
#&gt;   Oedema due to cardiac disease                                                  0                  1 (4.8%)                 0       
#&gt;   Pericardial effusion                                                           0                  1 (4.8%)                 0       
#&gt;   Right ventricular enlargement                                                  0                  1 (4.8%)                 0       
#&gt; 
#&gt; Metabolism and nutrition disorders
#&gt;   Total number of patients with at least one adverse event                    1 (9.1%)              2 (9.5%)                 0       
#&gt;   Total number of events                                                         1                     2                     0       
#&gt;   Infantile scurvy                                                               0                  1 (4.8%)                 0       
#&gt;   Osteoporotic fracture                                                          0                  1 (4.8%)                 0       
#&gt;   Pseudohypoparathyroidism                                                    1 (9.1%)                 0                     0       
#&gt; 
#&gt; Product issues
#&gt;   Total number of patients with at least one adverse event                       0                  1 (4.8%)             2 (11.1%)   
#&gt;   Total number of events                                                         0                     1                     2       
#&gt;   Product closure issue                                                          0                     0                  1 (5.6%)   
#&gt;   Product outer packaging issue                                                  0                  1 (4.8%)                 0       
#&gt;   Product packaging counterfeit                                                  0                     0                  1 (5.6%)   
#&gt; 
#&gt; Immune system disorders
#&gt;   Total number of patients with at least one adverse event                       0                  1 (4.8%)              1 (5.6%)   
#&gt;   Total number of events                                                         0                     1                     1       
#&gt;   Corneal graft rejection                                                        0                     0                  1 (5.6%)   
#&gt;   Cutaneous malacoplakia                                                         0                  1 (4.8%)                 0       
#&gt; 
#&gt; Social circumstances
#&gt;   Total number of patients with at least one adverse event                       0                  1 (4.8%)              1 (5.6%)   
#&gt;   Total number of events                                                         0                     1                     1       
#&gt;   Early adult transition                                                         0                     0                  1 (5.6%)   
#&gt;   Suicide of relative                                                            0                  1 (4.8%)                 0       
#&gt; 
#&gt; Ear and labyrinth disorders
#&gt;   Total number of patients with at least one adverse event                    1 (9.1%)                 0                     0       
#&gt;   Total number of events                                                         1                     0                     0       
#&gt;   Deaf mutism                                                                 1 (9.1%)                 0                     0       
#&gt; 
#&gt; Endocrine disorders
#&gt;   Total number of patients with at least one adverse event                       0                     0                  1 (5.6%)   
#&gt;   Total number of events                                                         0                     0                     1       
#&gt;   Thyroid cancer                                                                 0                     0                  1 (5.6%)   
#&gt; 
#&gt; Hepatobiliary disorders
#&gt;   Total number of patients with at least one adverse event                       0                  1 (4.8%)                 0       
#&gt;   Total number of events                                                         0                     1                     0       
#&gt;   Hepatic echinococciasis                                                        0                  1 (4.8%)                 0       
#&gt; 
#&gt; Psychiatric disorders
#&gt;   Total number of patients with at least one adverse event                       0                     0                  1 (5.6%)   
#&gt;   Total number of events                                                         0                     0                     1       
#&gt;   Abulia                                                                         0                     0                  1 (5.6%)   </div><div class='input'>
</div></pre>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="sidebar">
    <h2>Contents</h2>
    <ul class="nav nav-pills nav-stacked">
      <li><a href="#arguments">Arguments</a></li>
      <li><a href="#value">Value</a></li>
      <li><a href="#details">Details</a></li>
      <li><a href="#examples">Examples</a></li>
    </ul>

    <h2>Author</h2>
    <p>Carolyn Zhang (zhanc107) <a href='mailto:carolyn.zhang@duke.edu'>carolyn.zhang@duke.edu</a></p>
  </div>
</div>


      <footer>
      <div class="copyright">
  <p>Developed by Nina Qi, Chendi Liao, Mahdi About, Fei Wang, Mika Maekinen.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.4.1.</p>
</div>

      </footer>
   </div>

  


  </body>
</html>


